Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02618577
What this trial is testing

Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Who this might be right for
Atrial High Rate Episodes
Atrial Fibrillation Network 2,608
Not applicableStudy completedNCT02597920
What this trial is testing

Patient Convenience Study

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,852
Not applicableStudy completedNCT04195113
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

Who this might be right for
Atrial FibrillationVenous ThromboembolismArterial Vascular Disease
McMaster University 242
Large-scale testing (Phase 3)Active Not RecruitingNCT05825573
What this trial is testing

Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus

Who this might be right for
Intracardiac ThrombusSTEMIHeart Failure
Centre Hospitalier Universitaire de Nīmes 340
Not applicableStudy completedNCT05022563
What this trial is testing

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Who this might be right for
Venous Thromboembolism
Pfizer 55,759
Not applicableNot Yet RecruitingNCT06138184
What this trial is testing

Learning Theory Patient Education for Anticoagulants

Who this might be right for
Knowledge, Attitudes, Practice
University of Utah 68
Not applicableLooking for participantsNCT04660747
What this trial is testing

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,300
Not applicableStudy completedNCT02427516
What this trial is testing

Cost of Monitoring Patients Treated With Vitamin K Antagonists in Spain

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 1,144
Not applicableNot Yet RecruitingNCT06864052
What this trial is testing

The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

Who this might be right for
StrokeAtrial Fibrillation
Ewha Womans University Seoul Hospital 400
Not applicableStudy completedNCT01349530
What this trial is testing

Evaluating of CREATIF an Anti-coagulation Clinic

Who this might be right for
Vitamin K Antagonist
Assistance Publique - Hôpitaux de Paris 110
Not applicableLooking for participantsNCT05283174
What this trial is testing

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.

Who this might be right for
Therapeutic Drug Monitoring
National Taiwan University Hospital 500
Not applicableStudy completedNCT04117048
What this trial is testing

INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)

Who this might be right for
Vitamine K Antagonist (VKA) TreatmentInternational Normalized Ratio (INR) Measure at HomeThromboembolic Pathology
Medicalps 128
Not applicableStudy completedNCT02610153
What this trial is testing

Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies

Who this might be right for
Atrial Fibrillation
Bayer 1,013
Not applicableNot Yet RecruitingNCT07378514
What this trial is testing

Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices

Who this might be right for
Blood ClotsInfection and Inflammatory ReactionHeart Disease+5 more
LumiraDx UK Limited 30,000
Not applicableUnknownNCT04007653
What this trial is testing

Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE

Who this might be right for
Venous Thromboembolic DiseasePost Thrombotic SyndromeChronic Thromboembolic Pulmonary Hypertension+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,200
Not applicableStudy completedNCT02657616
What this trial is testing

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Who this might be right for
Atrial FibrillationStroke Prophylaxis
Institut für Pharmakoökonomie und Arzneimittellogistik e.V. 204,464
Large-scale testing (Phase 3)UnknownNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Post-approval studies (Phase 4)Looking for participantsNCT06187311
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital 940
Not applicableUnknownNCT04419012
What this trial is testing

Polish Atrial Fibrillation (POL-AF) Registry

Who this might be right for
Atrial Fibrillation
Jan Kochanowski University 4,000
Large-scale testing (Phase 3)Study completedNCT01830543
What this trial is testing

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Who this might be right for
Atrial FibrillationPercutaneous Coronary Intervention
Janssen Scientific Affairs, LLC 2,124
Next Page